Long-term Immune Protection in COVID-19 Patients

Overview

Acronym
LIPiC
Investigators
Dr. Ishac Nazy
McMaster University
Contacts
Rumi Clare
McMaster University

General Design

Study design
Cohort
Start - End Year
2020 -
General Information on Follow Up (profile, frequency)
Recruitment Target
  • Individuals
Number of Participants
600
Number of Participants with Biological Samples
600
Supplementary information about number of participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

LIPiC - Positive Cohort

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Ontario
Territory
Hamilton
Health Status
Other Criteria

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information

Sample Size

Number of Participants
200
Number of Participants with Biological Samples
200

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 LIPiC - Positive Cohort - Baseline
  • Biosamples
  • Blood
2020 (September) Ongoing
1 LIPiC - Positive Cohort - Follow-up 1
  • Biosamples
  • Blood
2021 (March) Ongoing
2 LIPiC - Positive Cohort - Follow-up 2
  • Biosamples
  • Blood
2021 (September) Ongoing
LIPiC - Negative Cohort

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Ontario
Territory
Hamilton
Health Status
Other Criteria

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information

Sample Size

Number of Participants
200
Number of Participants with Biological Samples
200

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 LIPiC - Negative Cohort - Baseline
  • Biosamples
  • Blood
2020 (September) Ongoing
1 LIPiC - Negative Cohort - Follow-up 1
  • Biosamples
  • Blood
2021 (March) Ongoing
2 LIPiC - Negative Cohort - Follow-up 2
  • Biosamples
  • Blood
2021 (September) Ongoing
LIPiC - Vaccinated Cohort

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Ontario
Territory
Hamilton
Health Status
Other Criteria

Sources of Recruitment

General Population
  • Selected sample

Sample Size

Number of Participants
200
Number of Participants with Biological Samples
200

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 LIPiC - Vaccinated Cohort - Baseline
  • Biosamples
  • Blood
2021 (March) Ongoing
1 LIPiC - Vaccinated Cohort - 3 weeks post-vaccination 1
  • Biosamples
  • Blood
2021 (April) Ongoing
2 LIPiC - Vaccinated Cohort - 3 weeks post-vaccination 2
  • Biosamples
  • Blood
2021 (May) Ongoing
3 LIPiC - Vaccinated Cohort - 6 months post-vaccination
  • Biosamples
  • Blood
2021 (September) Ongoing
4 LIPiC - Vaccinated Cohort - 12 months post-vaccination
  • Biosamples
  • Blood
2022 (March) Ongoing

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2024-02-27T14:37:40.218